Advertisement

Myocardial Perfusion Imaging in Specific Patient Populations

  • Raja C. PullattEmail author
  • Gary V. Heller
  • Gary V. Heller
Chapter

Abstract

Previous sections have given direction to use of myocardial perfusions in general categories of patients with or without CAD in large patient segments such as those with and without CAD. A major strength of the literature in Nuclear Cardiology is the wealth of data in the assessment of specific patient groups. This chapter will review the use of stress radionuclide perfusion imaging in the diagnosis and risk stratification of specific patient groups such as women, the elderly, diabetic patients and those with chronic kidney disease (CKD).

Keywords

Coronary Artery Disease Chronic Kidney Disease Myocardial Perfusion Imaging Chronic Kidney Disease Patient Exercise Tolerance Testing 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics – 2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18–e209.PubMedCrossRefGoogle Scholar
  2. 2.
    Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986;111(2):383–90.PubMedCrossRefGoogle Scholar
  3. 3.
    Marrugat J, Sala J, Masia R, Pavesi M, Sanz G, Valle V, et al. Mortality differences between men and women following first myocardial infarction. RESCATE Investigators. Recursos Empleados en el Sindrome Coronario Agudo y Tiempo de Espera. JAMA. 1998;280(16):1405–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Hendel RC, Abbott BG, Batemon TM, Blankstein R, Calnon DA, Leppo JA, et al. The role radionuclide myocardial perfusion imaging in a symptomatic individuals. J. Nucl Cardiol. 2011;18:3–15.Google Scholar
  5. 5.
    Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to update the 1997 exercise testing guidelines). Circulation. 2002;106(14):1883–92.PubMedCrossRefGoogle Scholar
  6. 6.
    Guiteras P, Chaitman BR, Waters DD, Bourassa MG, Scholl JM, Ferguson RJ, et al. Diagnostic accuracy of exercise ECG lead systems in clinical subsets of women. Circulation. 1982;65(7):1465–74.PubMedCrossRefGoogle Scholar
  7. 7.
    Barolsky SM, Gilbert CA, Faruqui A, Nutter DO, Schlant RC. Differences in electrocardiographic response to exercise of women and men: a non-Bayesian factor. Circulation. 1979;60(5):1021–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Mieres JH, Shaw LJ, Arai A, Budoff MJ, Flamm SD, Hundley WG, et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation. 2005;111(5):682–96.PubMedCrossRefGoogle Scholar
  9. 9.
    Naidoo VV. Review of gated SPECT imaging in women with suspected coronary heart disease. J Nucl Cardiol. 2006;13(4):474–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Amanullah AM, Kiat H, Friedman JD, Berman DS. Adenosine technetium-99m sestamibi myocardial perfusion SPECT in women: diagnostic efficacy in detection of coronary artery disease. J Am Coll Cardiol. 1996;27(4):803–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Taillefer R, DePuey EG, Udelson JE, Beller GA, Latour Y, Reeves F. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol. 1997;29(1):69–77.PubMedCrossRefGoogle Scholar
  12. 12.
    Valeti US, Miller TD, Hodge DO, Gibbons RJ. Exercise single-photon emission computed tomography provides effective risk stratification of elderly men and elderly women. Circulation. 2005;111(14):1771–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Hachamovitch R, Kang X, Amanullah AM, Abidov A, Hayes SW, Friedman JD, et al. Prognostic implications of myocardial perfusion single-photon emission computed tomography in the elderly. Circulation. 2009;120(22):2197–206.PubMedCrossRefGoogle Scholar
  14. 14.
    Nair SU, Ahlberg AW, Mathur S, Katten DM, Polk DM, Heller GV. The clinical value of single photon emission computed tomography myocardiol perfusion imaging in cardiac risk stratification of very elderly patients (≥ 80 years) with suspected coronary artery disease. J Nucl Cardiol 2012;19:244–55.Google Scholar
  15. 15.
    Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229–34.PubMedCrossRefGoogle Scholar
  16. 16.
    National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–421.Google Scholar
  17. 17.
    Kang X, Berman DS, Lewin H, Miranda R, Erel J, Friedman JD, et al. Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. Am Heart J. 1999;137(5):949–57.PubMedCrossRefGoogle Scholar
  18. 18.
    Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation. 2002;105(1):32–40.PubMedCrossRefGoogle Scholar
  19. 19.
    Barmpouletos D, Stavens G, Ahlberg AW, Katten DM, O’Sullivan DM, Heller GV. Duration and type of therapy for diabetes: impact on cardiac risk stratification with stress electrocardiographic-gated SPECT myocardial perfusion imaging. J Nucl Cardiol. 2010;17(6):1041–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA. 2009;301(15):1547–55.PubMedCrossRefGoogle Scholar
  21. 21.
    Zoccali C. Left ventricular systolic dysfunction: a sudden killer in end-stage renal disease patients. Hypertension. 2010;56(2):187–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, et al. The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol. 2007;50(3):217–24.PubMedCrossRefGoogle Scholar
  23. 23.
    Hatta T, Nishimura S, Nishimura T. Prognostic risk stratification of myocardial ischaemia evaluated by gated myocardial perfusion SPECT in patients with chronic kidney disease. Eur J Nucl Med Mol Imaging. 2009;36(11):1835–41.PubMedCrossRefGoogle Scholar
  24. 24.
    Hakeem A, Bhatti S, Dillie KS, Cook JR, Samad Z, Roth-Cline MD, et al. Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death. Circulation. 2008;118(24):2540–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Al-Mallah MH, Hachamovitch R, Dorbala S, Di Carli MF. Incremental prognostic value of myocardial perfusion imaging in patients referred to stress single-photon emission computed tomography with renal dysfunction. Circ Cardiovasc Imaging. 2009;2(6):429–36.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  • Raja C. Pullatt
    • 1
    Email author
  • Gary V. Heller
    • 2
  • Gary V. Heller
    • 3
  1. 1.Union County Cardiology AssociatesUnionUSA
  2. 2.University of Connecticut School of MedicineFarmingtonUSA
  3. 3.Intersocietal Accreditation CommissionEllicott CityUSA

Personalised recommendations